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httpObjective: This study aimed to evaluate the outcome and predisposing factors related to perioperative bleeding
in patients treated with endovascular aneurysm repair (EVAR) for ruptured and non-ruptured abdominal aortic
aneurysm (AAA).
Design: This was a retrospective cohort study.
Methods: A total of 525 consecutive patients (73% elective) with AAA underwent EVAR at two vascular centres
from 2008 to 2011. From registry data perioperative bleeding was analysed in relation to outcome and
preoperative data.
Results: A total of 453 (86%) patients presented with a perioperative bleeding <1000 ml, 42 (8%) patients
1000e1999 ml, 19 (4%) patients 2000e5000 ml and 11 (2%) >5000 ml. Other than ruptured AAA (n ¼ 90), no
preoperative risk factors for increased perioperative bleeding were found. Open femoral artery access
(n ¼ 101), branched (n ¼ 18) and uni-iliacal endografts (n ¼ 18) and introducer size were associated with
increased perioperative bleeding (P < 0.001). In multivariable logistic regression only rupture and perioperative
bleeding >2000 ml were signiﬁcantly related to 30-day mortality (odds ratio 10.6 (range 3.8e29.6) and 13.4
(range 4.8e37.4), respectively). Postoperative renal failure, multi-organ failure, >5 days at intensive care unit,
bowel ischaemia and abdominal compartments syndrome were signiﬁcantly related to perioperative bleeding
>2000 ml (P < 0.001).
Conclusion: Large perioperative bleeding during EVAR is a clinical problem that affects outcome. About 10% of
elective AAA patients and 34% of patients with ruptured AAA, undergoing EVAR, present a perioperative blood
loss exceeding 1 l. In our study, a perioperative blood loss exceeding 2 l was independently associated with
increased mortality and morbidity in both acute and elective AAA patients. Open femoral access, branched EVAR
and larger diameter introducers were associated with increased perioperative blood loss.
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Postoperative complicationsINTRODUCTION
Life-threatening bleeding in aortic aneurysm repair is
a feared perioperative complication. In open aortic surgery
massive blood loss is associated with increased mortality.1,2
Endovascular aneurysm repair (EVAR) is an established
method of treatment of infrarenal abdominal aortic aneu-
rysms (AAAs) if technically feasible.3 The method is associ-
ated with a lower perioperative blood loss compared to the
open approach.4e6 However, few studies have investigated
perioperative bleeding in EVAR and its impact on outcome.
In EVAR visible and measurable bleeding occurs at the
femoral or brachial artery access sites. Intra-abdominal
bleeding from the aorta, its branches and the iliac arteriesrresponding author. Tel.: þ46 (8) 517 740 58; fax: þ46 (8) 517
il address: carl.montan@karolinska.se (C. Montán).
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://dx.doi.org/10.1016/j.ejvs.2013.02.011can also occur after rupture or by iatrogenic injury. Previous
studies have investigated perioperative bleeding related
to closure devices and other methods of access site
closure.7e10 The aim of the present study was to evaluate
outcome and predisposing factors related to perioperative
bleeding in patients treated with both elective and emer-
gent EVARs.MATERIAL AND METHODS
This was a retrospective cohort study of consecutive
patients undergoing EVAR for AAA at the two largest
vascular centres in Sweden, Karolinska University Hospital
and Malmö Vascular Centre, from 1 April 2008 until 31
August 2011. Patients treated with elective or emergent
EVAR were considered for the study. Patients treated for
ruptured AAA, obviously being different in their presenta-
tion and outcome compared with elective cases, were
separately analysed as appropriate. Aneurysm morphology
and symptoms decided the treatment method and vascular
access route.
Table 1. Demographics.
Factor Non-ruptured AAA
(n ¼ 435)
Ruptured AAA
(n ¼ 90)
Age 73 (50e89) 74 (58e89)
Male sex 370/435 (85 %) 73/90 (81%)
Comorbidities
Diabetes 31/286 (11 %) 13/60 (22 %)
Hypertension 210/283 (74 %) 41/55 (74 %)
Heart risk 105/278 (38 %) 24/55 (44 %)
Blood chemistry
Hb 135 (69e173) 131 (75e169)
s-Creatinine
(micromol/L)
93 (42e956) 109 (35e373)
PK-INR 1.0 (0.8e4.6) 1.0 (0.9e3.1)
Medical therapy
Acetylsalicylic acid 301/432 (69 %) 46/88 (51%)
Clopidogrel 15/431 (3.4 %) None reported
Warfarin 42/432 (9.6 %) 5/88 (5.6%)
AAA e Abdominal Aortic Aneurysm; PK-INR e Prothrombin
complex-International Normalised Ratio.
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Data were collected from the Swedish Vascular Registry
(Swedvasc), a national registry with high compliance, and
local hospital medical records.11 Incomplete or non-existing
data in the registry were obtained from medical records.
Preoperative data including demographics, smoking habits,
co-morbidities, medical therapy, aneurysm morphology and
indication of procedure (elective, symptomatic or ruptured
aneurysm) were collected. Blood chemistry data were
collected from the hospital’s local laboratory data banks.
Data including access route, stent-graft manufacturer,
introducer size, number of components and method of
closure were retrieved from the operative charts as well as
procedure-related information such as methods of anaes-
thesia, perioperative haemodynamic instability, visualised
endoleak and type of endoleak on completion angiography.
Procedure time was captured from the local computerised
surgery-planning programme (Orbit, EVRY Health & Care
AB, Kristianstad, Sweden).
Outcome measures
Primary outcome measures were 30-day mortality, re-
operation and conversion to open surgery. Secondary
outcome measures were postoperative complications such as
myocardial infarction (MI), stroke, respiratory insufﬁciency and
dialysis-dependent renal failure and length of hospital stay.
Perioperative blood loss
The blood loss volume was collected from the operative
report, anaesthetist’s medical chart and Swedvasc. Peri-
operative blood loss was estimated from operative lap
sponges and volume of blood collected from suction. In
ruptured AAA cases with intra-abdominal haemorrhage on
computed tomography (CT) and/or signs of ongoing
bleeding, the total blood loss was estimated on established
measured factors such as haemodynamic parameters
(pulse, blood pressure and patient’s estimated blood
volume), the initial haematocrit and the volume of peri-
operative ﬂuid requirements and transfusion of blood
products.12,13 Blood loss was grouped into <1000, 1000e
1999, 2000e4999 and >5000 ml according to practice and
standard in Swedvasc. The perioperative bleeding volume
was analysed in relation to outcome and preoperative
data. Subgroup analysis was performed as appropriate for
elective and ruptured groups.
Ethics
The Regional Ethics Committee of Stockholm approved the
study.
Statistical analysis
Data analysis was performed using Statistical Package for
the Social Sciences (SPSS), version 19.0 (IBM, New York, NY,
USA). Descriptive statistics, including means, medians,
standard deviations, ranges, interquartile ranges (IQRs) and
proportions, were calculated as appropriate. Chi-squared orFisher’s exact tests were used as appropriate to compare
nominal variables between groups. Univariable analysis of
binary, nominal and ordinate variables was performed.
Variables associated with increased blood loss (P < 0.05 in
univariable analysis) were analysed in a logistical regression
model. Signiﬁcant relationships were expressed as odds
ratio (OR) with 95% conﬁdence interval (CI). P values <0.05
were considered to be statistically signiﬁcant.
RESULTS
Demographics and pre-, intra- and postoperative
descriptive data
A total of 525 patients with AAAs undergoing EVAR were
included in the study. A total of 203 patients (28% of all
patients treated for AAA) were treated by open aneurysm
surgery during the study period and were not considered
for the study. Patients lost to follow-up (n ¼ 2; foreign
referrals followed up in their home countries) were
excluded. Mean age was 73 (46e89) years; 441 (84%) were
men. Demographic data are presented in Table 1.
A total of 382 patients (73%) were elective cases, 53
patients (10%) were symptomatic and 90 (17%) were
ruptured AAAs. Conventional EVAR stent grafts were used
from Cook (n ¼ 352), Medtronic (n ¼ 79), Gore (n ¼ 1
3), Anaconda (n ¼ 1) and custom-made (n ¼ 1). For
fenestrated (n ¼ 61) and branched (n ¼ 18) endovascular
cases, the Cook stent grafts were used. Median number of
components used for EVAR procedures in patients was 3
(range 1e6) and did not differ between ruptured and non-
ruptured AAAs. Median introducer size on the ipsilateral
side was 20 (range 11e24) Fr (French) (total) and on
the contralateral side it was 14 (range 14e16) Fr for
non-ruptures and 16 Fr (range 14e16) for ruptures. Median
operative time was 180 (range 69e686) minutes for non-
ruptures and 180 (range 90e477) minutes for ruptures.
Median duration of hospital stay was 5 (IQR ¼ 3) days for
non-ruptures and 9 days (IQR ¼ 11) for ruptures.
Table 2. Perioperative bleeding volume in relation to non-ruptured and ruptured AAA.
Volume (ml) Elective
n ¼ 382
Symptomatic
n ¼ 53
Ruptured
n ¼ 90
Total
n ¼ 525
<1000 344 (90 %) 49 (93 %) 60 (67 %) 453 (86 %)
1000e1999 29 (8 %) 2 (4 %) 11 (12 %) 42 (8 %)
2000e5000 8 (2 %) 1 (2 %) 10 (11%) 19 (4 %)
>5000 1 (<0.5 %) 1 (2 %) 9 (10 %) 11 (2%)
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suture (FS) (n ¼ 263) or ProStarXL (PS) (n ¼ 159) was used
in 422 patients (81%). The most common method of access
site closure was FS (n ¼ 261 patients/522 access sites).
Conversions of FS to cut down and open raphie were
considered as failures, n ¼ 58/522 (7%; 5.5% bleeding and
1.5% occlusions). A total of 26 out of 302 of PS (8.6%) failed
due to bleeding and had to be converted to FS or open cut
down.
Five EVAR procedures (one elective case and four acute
cases) were converted to open surgery: aortobifemoral
bypass (n ¼ 3), aortobiiliac bypass (n ¼ 1) and axillobife-
moral bypass (n ¼ 1). The elective case was converted
because of severe endoleak and in the acute cases stent-
graft migration, dislocation and no stent-graft availability
required conversion to open surgery.Perioperative bleeding related to preoperative and
perioperative data
A total of 453 of all cases (86.3%) presented a bleeding
<1000 ml. Forty-two patients (8%) were reported to have
a blood loss between 1000 and 1999 ml, 19 (3.6%) 2000 and
5000 ml and 11 (2.1%) >5000 ml. Data on non-ruptured
and ruptured AAA patients are presented in Table 2.
Co-morbidities, anti-thrombotic medications or preoper-
ative laboratory data were not statistically signiﬁcantly
associated with risk of increased perioperative bleeding.
Open femoral artery access (n ¼ 101), branched (n ¼ 18)
and uniiliac (n ¼ 18) endografts, introducer size and
aneurysm diameter were all signiﬁcantly associated withTable 3. Perioperative variables related to bleeding volume.
Bleeding volume (ml) <1000
(n ¼ 453)
1000e1999
(n ¼ 42)
Method of access and femoral closure
Open accessa 60 20
Closure devicea 156 2
Fascia Suturea 235 20
Ruptured 60 11
Non ruptured 393 31
Fenestrated (n) vs. standard 56 5
Branched (n) vs. standard 11 5
Uni-iliac 13 0
Introducer sizeb,c 19 22
Aneurysm diameter (mm)c 59 67
a Primary method of access site closure (n ¼ 523 patients). Chi2 acco
b Ipsilateral side (median).
c Correlations according to Spearman. P values refer to distribution dilarger perioperative bleeding (P < 0.001). Fenestrated EVAR
(n ¼ 61), inﬂammatory (n ¼ 13) or infected (n ¼ 3) aneu-
rysms and procedure time were not associated with
increased bleeding.
Primary open access showed a signiﬁcantly higher asso-
ciation with increased bleeding compared to percutaneous
approach (P < 0.001). For primary open accesses 41
patients out of 101 (40.6%) presented a perioperative
bleeding of >1000 ml (P < 0.001). Twenty-eight patients
out of 263 (10.6%) who underwent FS had perioperative
bleeding >1000 ml. Three out of 159 (1.9%) patients
undergoing closure with PS bled >1000 ml. Data are pre-
sented in Table 3.Outcome related to perioperative bleeding
The 30-day mortality rate was 0.8% (3/382) in elective
patients and in symptomatic and ruptured AAA patients
5.5% (3/53) and 21% (19/90), respectively. At 30-day follow-
up a total complication rate of 22.8% (n ¼ 120/525) was
reported, including re-operation for bleeding 23 (4.4%),
postoperative MI 9 (1.7%), renal insufﬁciency 19 (3.6%),
multi-organ failure (MOF) 13 (2.5%), graft occlusion 5 (1%),
endoleak 15 (2.9%) and abdominal compartment syndrome
(ACS) 10 (1.9%). Among other complications reported were
cerebrovascular insult (n ¼ 4), venous injuries after FS
(n ¼ 2), covered renal artery (n ¼ 4), postoperative septi-
caemia (n ¼ 2), iliac artery dissection (n ¼ 2), iliac artery
rupture (n ¼ 1), pseudo-aneurysm brachial artery (n ¼ 1),
total dislocation of main body stent graft into aneurysm sac
(n ¼ 1) and aortoenteric ﬁstula (n ¼ 1).2000e5000
(n ¼ 19)
>5000
(n ¼ 11)
Total
(n ¼ 525)
P value
[523 (2 dead)]
10 11 101
<0.0011 0 159
8 0 263
10 9 90
<0.001
9 2 435
0 0 61 N/S
2 0 18 <0.001
4 1 18 <0.001
22 22 20 <0.001
71 70 61 <0.001
rding to Monte Carlo method.
fferences across bleeding volume groups.
Table 4. Univariable and multivariable analysis of factors inﬂuencing 30-day mortality total cohort.
Effect Univariable analysis Multivariable analysis
OR 95% CI P value OR 95% CI P value
Age >80 y 2.8 1.2e6.6 0.02 e e N/S
Pre-op s-creatinine >120 3.3 1.4e7.3 0.004 e e N/S
Aneurysm diameter >7 cm 4.8 2.0e11.8 0.001 e e N/S
Rupture 19.1 7.4e49.6 <0.001 10.6 3.8e29.6 <0.001
Bleeding >2000 ml 30.8 12.2e77.4 <0.001 13.4 4.8e37.4 <0.001
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>70 mm, ruptured AAA and perioperative bleeding
>2000 ml were signiﬁcantly associated with 30-day
mortality (P < 0.01) in univariable logistic regression anal-
ysis of pooled data from all patients. In multivariable logistic
regression analysis, only ruptured AAA and perioperative
bleeding >2000 ml were signiﬁcantly associated with
30-day mortality (OR 10.6 (95% CI 3.8e29.6) and OR 13.4
(95% CI 4.8e37.4), respectively). Data are presented in
Table 4.
Multivariable logistic regression analysis in the ruptured
group showed that perioperative bleeding >2000 ml was
signiﬁcantly associated with increased mortality (OR 10.68
(95% CI 3.2e36.1)) P < 0.001.
Also in the non-ruptured group, although few events,
perioperative bleeding of >2000 ml (n ¼ 11) was signiﬁ-
cantly associated with 30-day mortality (n ¼ 6) (OR 30 (95%
CI 3.6e145)) P ¼ 0.001.
In non-ruptured and ruptured AAA cases (separately
analysed), postoperative renal failure, MOF, >5 day stay in
intensive care unit (ICU), bowel ischaemia and ACS were all
postoperative complications signiﬁcantly related to peri-
operative bleeding in the multivariable analysis (P < 0.001).
Data are presented in Tables 5a and b. Other complications
such as MI, cerebrovascular insult, re-operation, endoleak
and overall mean length of hospital stay were not signiﬁ-
cantly related to bleeding volume.DISCUSSION
An advantage of EVAR compared to open approach is the
decreased perioperative bleeding, 200e400 ml versus
1000e1500 ml in elective cases.4e6,14 Blood loss in elective
EVAR is most commonly a result of leakage from guide wire
and sheath exchanges and from complications during access
site closure.Table 5a. Outcome related to intraoperative bleeding in EVAR patient
Bleeding volume ml
(Total 435)
<1000
(393)
1000e1999
(31)
Dead 30-days (n) 4 0
Renal failure (n) 7 0
MOF (n) 0 0
>5 days at ICU (n) 2 0
Bowel ischemia (n) 1 0
ACS (n) 1 0
EVAR ¼ Endovascular Aneurysm Repair, MOF ¼ Multi Organ Failur
Syndrome. Chi2 according to Monte Carlo method. P-values refer acroTo our knowledge no previous study has evaluated
outcome related to perioperative bleeding in acute and
elective EVARs. This study has shown that perioperative
blood loss exceeding 2 l, in patients treated with EVAR for
ruptured AAA, increases 30-day mortality rate. In multi-
variable analysis of the total patient cohort, perioperative
bleeding exceeding 2 l showed a stronger correlation to
mortality than ruptured AAA. This might be explained by
the observation that patients with a contained rupture,
without ongoing bleeding and need of massive transfusions,
often recover fast if there is no perioperative bleeding
complication. The few elective patients with blood loss
exceeding 2 l limit conclusions about the danger of large
bleedings in this group. Elective patients with a perioper-
ative blood loss >2 l showed a signiﬁcant increase in
postoperative complications.
Our data suggest that perioperative blood loss is not
associated with co-morbidities or preoperative blood
chemistry and coagulation data. Most often it seems to
relate to technical issues, such as open femoral artery
approach and access site closure problems.
Other risk factors for increased perioperative bleeding
related to technical factors were large-diameter introducers,
which concurs with previous studies, and branched EVAR.8,15
In branched EVAR, large-diameter introducers are often used
and these procedures tend to be longer which might explain
why branched EVARs tend to bleed more. However, proce-
dure time per se was not related to larger bleeding.
The safety of different methods of access site closure
has previously been analysed.7e10,16 Excellent results for
a closure device (double ProStarXL) used off-label for larger
introducer sizes than 18 Fr and FSs have been reported with
failure rates of 2e10%.16,17 In this study, FSs and closure
devices were equally good in obtaining haemostasis.
Massive blood loss, in open aortic surgery, is an inde-
pendent risk factor associated with increased mortality1,2s with non-ruptured abdominal aortic aneurysms.
2000e5000
(9)
>5000
(2)
Total P value
2 0 6 <0.001
1 2 10 <0.001
1 2 3 <0.001
1 2 5 <0.001
0 1 2 <0.001
0 2 3 <0.001
e, ICU ¼ Intensive Care Unit, ACS ¼ Abdominal Compartment
ss groups.
Table 5b. Outcome related to intraoperative bleeding in EVAR patients with ruptured Abdominal Aortic Aneurysm
Bleeding volume ml
(Total 90)
<1000
(60)
1000e1999
(11)
2000e5000
(10)
>5000
(9)
Total P value
Dead 30-days (n) 6 2 5 6 19 <0.001
Renal failure (n) 3 1 2 3 9 <0.001
MOF (n) 4 1 1 4 10 <0.001
>5 days at ICU (n) 5 1 2 4 12 <0.001
Bowel ischemia (n) 3 0 2 2 7 <0.001
ACS (n) 2 0 2 3 7 <0.001
EVAR ¼ Endovascular Aneurysm Repair, MOF ¼ Multi Organ Failure, ICU ¼ Intensive Care Unit, ACS ¼ Abdominal Compartment
Syndrome. Chi2 according to Monte Carlo method. P-values refer across groups.
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that it is important to perform a risk analysis of each patient
undergoing EVAR in terms of potential bleeding complica-
tions. Technical factors are important and it seems prefer-
able to avoid open femoral artery access and to use small
introducer sizes to decrease perioperative bleeding.
Preparedness for large perioperative bleeding is necessary
in ruptured AAA cases, as well as in advanced EVAR cases,
such as branched EVAR.
This study, limited by its retrospective nature, includes
the EVAR experience from two centres with both conven-
tional and more advanced reconstructions. Our 30-day
mortality rates for elective and ruptured cases are compa-
rable to previous studies.6,18
In patients undergoing EVAR for ruptured AAA, the internal
blood volume loss is difﬁcult to estimate.This is a limitation of
this study. We based our estimation of the perioperative
blood loss on established factors including haemodynamic
parameters and blood transfusion requirements. However, it
is well known that, in surgical procedures in general, the
perioperative estimated blood loss is both poorly reproduc-
ible and usually underestimated.12 It may be possible to
estimate the volume of the retroperitoneal or intra-
abdominal haematoma using CT and three-dimensional
(3D)-volume rendering techniques, but this has not been
established in AAA studies.19 The 3D-volume rendering
techniques have previously been used in calculating volume
of cerebral haematomas as a predictor for outcome.20
In conclusion, large perioperative haemorrhage during
EVAR is a clinical problem that affects outcome. Efforts
must be made to minimise perioperative blood loss. About
10% of elective AAA patients and 34% of patients with
ruptured AAA, undergoing EVAR, present a perioperative
blood loss exceeding 1 l. In our study, a perioperative blood
loss exceeding 2 l was independently associated with
increased mortality and morbidity in both acute and elec-
tive AAA patients. Open femoral access, branched EVAR and
larger-diameter introducers were associated with increased
perioperative blood loss.
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